Trademarkia Logo

Canada

C$
XIIDRA
REGISTERED

on 17 May 2023

Last Applicant/ Owned by

BAUSCH + LOMB IRELAND LIMITED

3013 Lake Drive, Citywest Business CampusDublin 24

IE

Serial Number

2050611 filed on 29th Jun 2020

Registration Number

TMA1179994 registered on 17th May 2023

Registration expiry Date

29th Jun 2030

XIIDRA

Trademark usage description

pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, Read More

Vienna Information


1 . 3 . 1

Sun rising or settingSoleil levant ou couchant

1 . 3 . 13

Sun with inscriptionsSoleil avec inscriptions

26 . 2 . 1

Segments of circles or ellipses (except 26.2.7)Segments de cercle ou d'ellipse (excepté 26.2.7)

26 . 2 . 24

Segments or sectors of circles or ellipses, semi-circles or semi-ellipses with dark surfaces or parts of surfacesSegments ou secteurs de cercles ou ellipses, demi-cercles ou demi-ellipses avec surface ou partie de la surface foncée

26 . 11 . 1

One line or one bandUne ligne ou une bande

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; antiinflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; anti-infectives, antibacterials, antivirals, antibiotics, systemic and topical antifungals.


Classification kind code

11

Mark Details


Serial Number

2050611

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 19th Jan 2022
Agent Changed
Submitted for opposition 22
on 5th Jan 2022
Search Recorded
Submitted for opposition 20
on 5th Jan 2022
Examiner's First Report
Submitted for opposition 223
on 5th Jan 2022
Total Provisional Refusal
Submitted for opposition 256
on 12th Jul 2021
Notification of Possible Opposition Sent
Submitted for opposition 257
on 10th Sept 2020
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 9th Sept 2020
Created
Submitted for opposition 31
on 9th Sept 2020
Formalized
Submitted for opposition 228
on 29th Jun 2020
International Registration
Submitted for opposition 30
on 29th Jun 2020
Filed